In a study, SD rats were treated with LPS to induce depression-like symptoms, and administration of carveol at doses of 20 mg/kg and 50 mg/kg demonstrated its ability to mitigate the LPS-induced effects and decrease OS by modulating the Nrf2 pathway [98]. Here, NFE2L2 is linked to major depressive disorder.